<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) March 18, 1997
-----------------------------
ALLERGAN, INC.
- -------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 1-10269 95-1622442
- -------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
2525 Dupont Drive, Irvine, California 92612
- -------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (714) 752-4500
---------------------------
N/A
- -------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
ITEM 5. OTHER EVENTS.
The Board of Directors of Allergan, Inc. ("Allergan") has elected not to submit
an extension of the term of the Rights Agreement dated as of May 18, 1989 (the
"Rights Agreement") between Allergan and Morgan Shareholder Services Trust
Company as amended by that certain Amendment dated as of September 28, 1993
between Allergan and First Chicago Trust Company of New York (as successor
Rights Agent to Morgan Shareholder Services Trust Company), to a vote of
Allergan stockholders at the next annual meeting. The Rights Agreement will,
by its terms, automatically expire at the Annual Meeting of Stockholders on
April 22, 1997.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ALLERGAN, INC.
Date: March 18, 1997 By: /s/ Francis R. Tunney, Jr.
--------------------------------
Francis R. Tunney, Jr.
Corporate Vice President,
General Counsel and Secretary
3
